HSBC Holdings’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $484M | Buy |
3,836,489
+646,150
| +20% | +$85.1M | 0.2% | 82 |
|
|
2026
Q1 | $444M | Sell |
3,190,339
-584,817
| -15% | -$81.9M | 0.23% | 76 |
|
|
2025
Q4 | $464M | Sell |
3,775,156
-169,869
| -4% | -$20.6M | 0.24% | 73 |
|
|
2025
Q3 | $440M | Buy |
3,945,025
+586,123
| +17% | +$66.6M | 0.24% | 66 |
|
|
2025
Q2 | $372M | Sell |
3,358,902
-668,884
| -17% | -$71.2M | 0.22% | 72 |
|
|
2025
Q1 | $450M | Sell |
4,027,786
-239,517
| -6% | -$24.7M | 0.28% | 60 |
|
|
2024
Q4 | $394M | Buy |
4,267,303
+105,787
| +3% | +$9.52M | 0.23% | 70 |
|
|
2024
Q3 | $349M | Sell |
4,161,516
-1,162,853
| -22% | -$88.7M | 0.2% | 84 |
|
|
2024
Q2 | $366M | Buy |
5,324,369
+853,524
| +19% | +$57M | 0.22% | 78 |
|
|
2024
Q1 | $327M | Buy |
4,470,845
+1,227,652
| +38% | +$94.4M | 0.22% | 82 |
|
|
2023
Q4 | $263M | Buy |
3,243,193
+468,942
| +17% | +$36.5M | 0.23% | 73 |
|
|
2023
Q3 | $208M | Sell |
2,774,251
-408,362
| -13% | -$31.4M | 0.22% | 78 |
|
|
2023
Q2 | $245M | Buy |
3,182,613
+382,092
| +14% | +$30.5M | 0.25% | 67 |
|
|
2023
Q1 | $232M | Sell |
2,800,521
-742,978
| -21% | -$61.5M | 0.28% | 62 |
|
|
2022
Q4 | $303M | Buy |
3,543,499
+1,190,780
| +51% | +$94.3M | 0.35% | 48 |
|
|
2022
Q3 | $146M | Buy |
2,352,719
+592,794
| +34% | +$37.4M | 0.24% | 72 |
|
|
2022
Q2 | $109M | Sell |
1,759,925
-623,767
| -26% | -$38.6M | 0.15% | 111 |
|
|
2022
Q1 | $142M | Buy |
2,383,692
+944,882
| +66% | +$60.4M | 0.17% | 103 |
|
|
2021
Q4 | $105M | Sell |
1,438,810
-146,395
| -9% | -$10.1M | 0.1% | 183 |
|
|
2021
Q3 | $111M | Sell |
1,585,205
-432,906
| -21% | -$30.4M | 0.11% | 148 |
|
|
2021
Q2 | $138M | Sell |
2,018,111
-537,994
| -21% | -$35.9M | 0.15% | 115 |
|
|
2021
Q1 | $166M | Sell |
2,556,105
-236,575
| -8% | -$15.3M | 0.2% | 103 |
|
|
2020
Q4 | $161M | Buy |
2,792,680
+489,609
| +21% | +$29.5M | 0.21% | 83 |
|
|
2020
Q3 | $145M | Sell |
2,303,071
-85,591
| -4% | -$5.94M | 0.23% | 73 |
|
|
2020
Q2 | $184M | Buy |
2,388,662
+389,195
| +19% | +$29.8M | 0.35% | 48 |
|
|
2020
Q1 | $150M | Buy |
1,999,467
+46,691
| +2% | +$3.23M | 0.35% | 49 |
|
|
2019
Q4 | $127M | Sell |
1,952,776
-99,154
| -5% | -$6.46M | 0.22% | 82 |
|
|
2019
Q3 | $130M | Buy |
2,051,930
+415,183
| +25% | +$27.1M | 0.24% | 71 |
|
|
2019
Q2 | $111M | Sell |
1,636,747
-931,100
| -36% | -$61.3M | 0.21% | 94 |
|
|
2019
Q1 | $167M | Buy |
2,567,847
+389,670
| +18% | +$25.9M | 0.3% | 59 |
|
|
2018
Q4 | $136M | Sell |
2,178,177
-80,435
| -4% | -$5.62M | 0.25% | 71 |
|
|
2018
Q3 | $174M | Sell |
2,258,612
-244,802
| -10% | -$18.5M | 0.28% | 62 |
|
|
2018
Q2 | $177M | Sell |
2,503,414
-608,822
| -20% | -$43M | 0.32% | 55 |
|
|
2018
Q1 | $235M | Sell |
3,112,236
-310,802
| -9% | -$24.7M | 0.35% | 48 |
|
|
2017
Q4 | $245M | Buy |
3,423,038
+674,320
| +25% | +$51.2M | 0.36% | 59 |
|
|
2017
Q3 | $223M | Sell |
2,748,718
-60,441
| -2% | -$4.62M | 0.36% | 52 |
|
|
2017
Q2 | $199M | Buy |
2,809,159
+458,846
| +20% | +$30.5M | 0.37% | 47 |
|
|
2017
Q1 | $160M | Buy |
2,350,313
+469,269
| +25% | +$33M | 0.33% | 54 |
|
|
2016
Q4 | $135M | Sell |
1,881,044
-158,084
| -8% | -$11.8M | 0.31% | 61 |
|
|
2016
Q3 | $161M | Buy |
2,039,128
+311,258
| +18% | +$25.3M | 0.4% | 46 |
|
|
2016
Q2 | $144M | Buy |
1,727,870
+233,369
| +16% | +$20.7M | 0.4% | 48 |
|
|
2016
Q1 | $137M | Sell |
1,494,501
-1,276,675
| -46% | -$115M | 0.39% | 54 |
|
|
2015
Q4 | $281M | Sell |
2,771,176
-306,290
| -10% | -$31.9M | 0.68% | 20 |
|
|
2015
Q3 | $302M | Buy |
3,077,466
+238,683
| +8% | +$26.5M | 0.76% | 21 |
|
|
2015
Q2 | $332M | Buy |
2,838,783
+323,259
| +13% | +$35.3M | 0.68% | 22 |
|
|
2015
Q1 | $247M | Buy |
2,515,524
+307,060
| +14% | +$31.2M | 0.47% | 40 |
|
|
2014
Q4 | $208M | Buy |
2,208,464
+335,532
| +18% | +$34.7M | 0.43% | 46 |
|
|
2014
Q3 | $200M | Sell |
1,872,932
-179,792
| -9% | -$17.6M | 0.42% | 50 |
|
|
2014
Q2 | $170M | Buy |
2,052,724
+327,781
| +19% | +$25.5M | 0.37% | 61 |
|
|
2014
Q1 | $122M | Buy |
1,724,943
+215,777
| +14% | +$16.9M | 0.29% | 70 |
|
|
2013
Q4 | $113M | Sell |
1,509,166
-531,547
| -26% | -$37M | 0.3% | 67 |
|
|
2013
Q3 | $128M | Buy |
2,040,713
+80,107
| +4% | +$4.79M | 0.35% | 58 |
|
|
2013
Q2 | $100M | Buy |
+1,960,606
| New | +$102M | 0.3% | 64 |
|
Other funds holding GILD
HSBC Holdings's GILD Position: Q2 2026 in Review
HSBC Holdings increased its Gilead Sciences (GILD) stake by 20% in Q2 2026, buying an estimated $85.1M and bringing the position to 3,836,489 shares worth $484M. The position accounts for 0.2% of the portfolio, ranked #82.
HSBC Holdings first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- HSBC Holdings held 3,836,489 shares of Gilead Sciences worth $484M as of Q2 2026.
- HSBC Holdings bought 646,150 Gilead Sciences shares in Q2 2026, an estimated $85.1M.
- Gilead Sciences made up 0.2% of HSBC Holdings's portfolio in Q2 2026, its #82 holding.
- HSBC Holdings first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.